MyJournals Home  

RSS FeedsAntibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus (BMC Medicine)

 
 

31 july 2020 06:11:27

 
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus (BMC Medicine)
 


Zika virus (ZIKV) infection is a global health problem, and its complications, including congenital Zika syndrome and Guillain-Barr&eaigu; syndrome, constitute a continued threat to humans. Unfortunately, effective ...


 
291 viewsCategory: Medicine
 
“The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic (BMC Medicine)
Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women (BMC International Health and Human Rights)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten